Lipid Signature May Flag Schizophrenia
A specific lipid profile can identify patients with schizophrenia, possibly paving the way to the first clinically useful diagnostic test for a severe psychiatric illness, new research suggests.
Stay updated with breaking news from Antipsychotics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A specific lipid profile can identify patients with schizophrenia, possibly paving the way to the first clinically useful diagnostic test for a severe psychiatric illness, new research suggests.
Patients often hide their hallucinations, which are associated with poor long-term outcomes and a reduced quality of life.
The Center for Medicare and Medicaid Services (CMMS) announced this week that it has begun auditing the nation's nursing homes to see if they are accurately diagnosing and treating elderly [...]
Over the past 20 years, antipsychotic prescribing in children and adolescents has more than doubled in England, with the largest increase in children with autism.
Topline results from an exploratory study suggest clinically meaningful benefits when evenamide is added to existing antipsychotic medication in adults with treatment-resistant schizophrenia.